{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,9,17]],"date-time":"2025-09-17T16:17:34Z","timestamp":1758125854040},"reference-count":33,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"1","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2014,1]]},"DOI":"10.1097\/pap.0000000000000002","type":"journal-article","created":{"date-parts":[[2013,12,6]],"date-time":"2013-12-06T10:16:38Z","timestamp":1386324998000},"page":"12-25","source":"Crossref","is-referenced-by-count":17,"title":["Hodgkin Lymphoma"],"prefix":"10.1097","volume":"21","author":[{"given":"Rebecca L.","family":"King","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Matthew T.","family":"Howard","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Adam","family":"Bagg","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","reference":[{"key":"R1-2-20210202","first-page":"69","article-title":"On some morbid appearances of the assorbant glands and spleen.","volume":"17","author":"Hodgkin","year":"1832","journal-title":"Med Chir Trans"},{"key":"R2-2-20210202","first-page":"133","article-title":"On the pathological changes in Hodgkins disease, with special reference to its relation to tuberculosis.","volume":"10","author":"Reed","year":"1902","journal-title":"Johns Hopkins Hosp Rep"},{"key":"R5-2-20210202","doi-asserted-by":"crossref","first-page":"11","DOI":"10.3322\/caac.21166","article-title":"Cancer statistics, 2013;CA.","volume":"63","author":"Siegel","year":"2013","journal-title":"Cancer J Clin"},{"key":"R7-2-20210202","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1016\/S0950-3536(96)80018-7","article-title":"The epidemiology of Hodgkins disease.","volume":"9","author":"Glaser","year":"1996","journal-title":"Baillieres Clin Haematol"},{"key":"R8-2-20210202","first-page":"92","article-title":"Epidemiology of Hodgkins disease.","volume":"7","author":"Gutensohn","year":"1980","journal-title":"Semin Oncol"},{"key":"R9-2-20210202","first-page":"1189","article-title":"The epidemiology of Hodgkins disease.","volume":"26","author":"MacMahon","year":"1966","journal-title":"Cancer Res"},{"key":"R10-2-20210202","doi-asserted-by":"crossref","first-page":"813","DOI":"10.1182\/blood.V57.5.813.813","article-title":"Hodgkins disease: biology, treatment, prognosis.","volume":"57","author":"Kaplan","year":"1981","journal-title":"Blood"},{"key":"R11-2-20210202","doi-asserted-by":"crossref","first-page":"2439","DOI":"10.1002\/1097-0142(19800515)45:10<2439::AID-CNCR2820451003>3.0.CO;2-1","article-title":"Hodgkins disease: unfolding concepts concerning its nature, management and prognosis.","volume":"45","author":"Kaplan","year":"1980","journal-title":"Cancer"},{"key":"R12-2-20210202","doi-asserted-by":"crossref","first-page":"1096","DOI":"10.1002\/ajh.23348","article-title":"Hodgkin lymphoma: 2012 update on diagnosis, risk-stratification, and management.","volume":"87","author":"Ansell","year":"2012","journal-title":"Am J Hematol"},{"key":"R14-2-20210202","doi-asserted-by":"crossref","first-page":"1812","DOI":"10.1200\/JCO.2010.32.8401","article-title":"Molecular pathogenesis of Hodgkins lymphoma: increasing evidence of the importance of the microenvironment.","volume":"29","author":"Steidl","year":"2011","journal-title":"J Clin Oncol"},{"key":"R18-2-20210202","doi-asserted-by":"crossref","first-page":"805","DOI":"10.1586\/14737159.7.6.805","article-title":"Recent insights into the biology of Hodgkin lymphoma: unraveling the mysteries of the Reed-Sternberg cell.","volume":"7","author":"Roullet","year":"2007","journal-title":"Expert Rev Mol Diagn"},{"key":"R23-2-20210202","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1038\/nature09754","article-title":"MHC class II transactivator CIITA is a recurrent gene fusion partner in lymphoid cancers.","volume":"471","author":"Steidl","year":"2011","journal-title":"Nature"},{"key":"R27-2-20210202","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1016\/j.jnci.2011.10.006","article-title":"High expression of LMO2 in Hodgkin, Burkitt and germinal center diffuse large B cell lymphomas.","volume":"23","author":"Shams","year":"2011","journal-title":"J Egypt Natl Canc Inst"},{"key":"R30-2-20210202","doi-asserted-by":"crossref","first-page":"1346","DOI":"10.1097\/00000478-200310000-00007","article-title":"Characterization of variant patterns of nodular lymphocyte predominant Hodgkin lymphoma with immunohistologic and clinical correlation.","volume":"27","author":"Fan","year":"2003","journal-title":"Am J Surg Pathol"},{"key":"R31-2-20210202","doi-asserted-by":"crossref","first-page":"S57","DOI":"10.1038\/modpathol.2012.182","article-title":"Shades of gray between large B-cell lymphomas and Hodgkin lymphomas: differential diagnosis and biological implications.","volume":"26","author":"Harris","year":"2013","journal-title":"Mod Pathol"},{"key":"R32-2-20210202","first-page":"599","article-title":"Lymphocyte predominant Hodgkins disease nodular subtype with coexistent large cell lymphoma.","volume":"12","author":"Sundeen","year":"1988","journal-title":"Histological progression or composite malignancyAm J Surg Pathol"},{"key":"R36-2-20210202","doi-asserted-by":"crossref","first-page":"1010","DOI":"10.1038\/modpathol.3800622","article-title":"Expression profiling of transcription factors Pax-5, Oct-1, Oct-2, BOB.1, and PU.1 in Hodgkins and non-Hodgkins lymphomas: a comparative study using high throughput tissue microarrays.","volume":"19","author":"McCune","year":"2006","journal-title":"Mod Pathol"},{"key":"R38-2-20210202","doi-asserted-by":"crossref","first-page":"558","DOI":"10.3324\/haematol.2010.033167","article-title":"Methylation profiling of mediastinal gray zone lymphoma reveals a distinctive signature with elements shared by classical Hodgkins lymphoma and primary mediastinal large B-cell lymphoma.","volume":"96","author":"Eberle","year":"2011","journal-title":"Haematologica"},{"key":"R40-2-20210202","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1016\/j.critrevonc.2008.07.020","article-title":"Primary mediastinal large B-cell lymphoma.","volume":"68","author":"Martelli","year":"2008","journal-title":"Crit Rev Oncol Hematol"},{"key":"R41-2-20210202","doi-asserted-by":"crossref","first-page":"262","DOI":"10.3324\/haematol.2010.030809","article-title":"Clinical, pathological and genetic features of primary mediastinal large B-cell lymphomas and mediastinal gray zone lymphomas in children.","volume":"96","author":"Oschlies","year":"2011","journal-title":"Haematologica"},{"key":"R42-2-20210202","doi-asserted-by":"crossref","first-page":"851","DOI":"10.1084\/jem.20031074","article-title":"Molecular diagnosis of primary mediastinal B cell lymphoma identifies a clinically favorable subgroup of diffuse large B cell lymphoma related to Hodgkin lymphoma.","volume":"198","author":"Rosenwald","year":"2003","journal-title":"J Exp Med"},{"key":"R43-2-20210202","doi-asserted-by":"crossref","first-page":"3871","DOI":"10.1182\/blood-2003-06-1841","article-title":"The molecular signature of mediastinal large B-cell lymphoma differs from that of other diffuse large B-cell lymphomas and shares features with classical Hodgkin lymphoma.","volume":"102","author":"Savage","year":"2003","journal-title":"Blood"},{"key":"R44-2-20210202","doi-asserted-by":"crossref","first-page":"1411","DOI":"10.1097\/01.pas.0000180856.74572.73","article-title":"Mediastinal gray zone lymphoma: the missing link between classic Hodgkins lymphoma and mediastinal large B-cell lymphoma.","volume":"29","author":"Traverse-Glehen","year":"2005","journal-title":"Am J Surg Pathol"},{"key":"R57-2-20210202","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1532\/IJH97.06048","article-title":"Genomic alterations in Hodgkins lymphoma.","volume":"83","author":"Weniger","year":"2006","journal-title":"Int J Hematol"},{"key":"R68-2-20210202","doi-asserted-by":"crossref","first-page":"1342","DOI":"10.1136\/jcp.2007.050146","article-title":"Contribution of the Epstein-Barr virus to the molecular pathogenesis of Hodgkin lymphoma.","volume":"60","author":"Kapatai","year":"2007","journal-title":"J Clin Pathol"},{"key":"R72-2-20210202","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1016\/j.blre.2010.08.003","article-title":"Novel treatment strategies for patients with relapsed classical Hodgkin lymphoma.","volume":"24","author":"Jona","year":"2010","journal-title":"Blood Rev"},{"key":"R73-2-20210202","doi-asserted-by":"crossref","first-page":"786","DOI":"10.1016\/S0140-6736(09)61878-X","article-title":"Developments in the management of Hodgkins lymphoma.","volume":"375","author":"Lowry","year":"2010","journal-title":"Lancet"},{"key":"R100-2-20210202","doi-asserted-by":"crossref","first-page":"736","DOI":"10.1093\/annonc\/mdr157","article-title":"Lack of association of tumor associated macrophages with clinical outcome in patients with classical Hogkins lymphoma.","volume":"23","author":"Azambuja","year":"2011","journal-title":"Ann Oncol"},{"key":"R102-2-20210202","doi-asserted-by":"crossref","first-page":"662","DOI":"10.1182\/blood-2005-12-5125","article-title":"Tumor microenvironment and mitotic checkpoint are key factors in the outcome of classic Hodgkin lymphoma.","volume":"108","author":"Sanchez-Aguilera","year":"2006","journal-title":"Blood"},{"key":"R103-2-20210202","doi-asserted-by":"crossref","first-page":"875","DOI":"10.1056\/NEJMoa0905680","article-title":"Tumor-associated macrophages and survival in classic Hodgkins lymphoma.","volume":"362","author":"Steidl","year":"2010","journal-title":"N Engl J Med"},{"key":"R107-2-20210202","doi-asserted-by":"crossref","first-page":"3439","DOI":"10.1172\/JCI61245","article-title":"Hodgkin lymphoma.","volume":"122","author":"Kuppers","year":"2012","journal-title":"J Clin Investig"},{"key":"R108-2-20210202","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1111\/bjh.12244","article-title":"Modern management of lymphocyte predominant Hodgkin lymphoma.","volume":"161","author":"Xing","year":"2013","journal-title":"Br J Haematol"},{"key":"R109-2-20210202","doi-asserted-by":"crossref","first-page":"1668","DOI":"10.1080\/10428190802163339","article-title":"Biologic features of Hodgkin lymphoma and the development of biologic prognostic factors in Hodgkin lymphoma: tumor and microenvironment.","volume":"49","author":"Hsi","year":"2008","journal-title":"Leuk Lymphom"}],"container-title":["Advances in Anatomic Pathology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/PAP.0000000000000002","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,5,14]],"date-time":"2021-05-14T04:38:33Z","timestamp":1620967113000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/00125480-201401000-00002"}},"subtitle":["Pathology, Pathogenesis, and a Plethora of Potential Prognostic Predictors"],"short-title":[],"issued":{"date-parts":[[2014,1]]},"references-count":33,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2014]]}},"URL":"https:\/\/doi.org\/10.1097\/pap.0000000000000002","relation":{},"ISSN":["1072-4109"],"issn-type":[{"value":"1072-4109","type":"print"}],"subject":[],"published":{"date-parts":[[2014,1]]}}}